The disease that kills you here is heart disease, not kidney failure. The same leaky vessels that let protein into your urine are failing in the arteries feeding your heart and brain ¹, and most people with early kidney disease die of a heart attack or stroke long before dialysis is on the table ². This is a cardiovascular reset as much as a kidney one.

It takes two numbers. Filtration (eGFR) says how fast your kidneys clean the blood; the urine albumin-to-creatinine ratio (uACR) says how much protein is leaking through. A standard panel measures the first and skips the second, and that protein test catches the highest-risk people. As nephrons are lost the survivors run at higher pressure and wear out faster, and every drug that helps works by taking that pressure off ³.

These drugs are settled science. Dapagliflozin cut kidney-and-heart bad outcomes by about 39% ⁴ and empagliflozin by about 28%, both with or without diabetes ⁵. ACE inhibitors and ARBs slow the slide toward dialysis ⁶, and tight blood pressure cut all-cause death by about a quarter ⁷. The catch: primary care runs years behind, so you may have to ask for the newer ones by name.

You decide this with your doctor — the drugs need a prescription and the monitoring needs labs. Know the plan anyway; a busy clinic often lags the guideline.

The win here is an absence of things going wrong. Nothing dramatic happens in three months; the disease was silent, and so is the treatment.

• One to two years: your eGFR stabilizes instead of drifting down, and your urine protein drops.
• Five to ten years: friends your age start getting their first stents and you don't. You keep the long walks and the stairs.
• The real payoff is the heart attack you didn't have and the dialysis you skipped ⁴ — one of the best deals in adult medicine.